Australian vaccine set for overseas test

The effectiveness of a University of Queensland vaccine for coronavirus is about to be tested in a biosecurity facility in the Netherlands.

The vaccine will be used on live coronavirus for the first time to determine how effectively it induces protection against infection.

UQ's vaccine program co-leader Dr Keith Chappell said the trial will establish a critical package of data ahead of human clinical trials later this year. Clinical studies will be conducted by Viroclinics Xplore which offers a myriad of preclinical tests including toxicology of drugs, antibodies, and antivirals targeting viral infectious diseases.

 

UQ created COVID-19 in its laboratory and then set about designing a vaccine to combat the virus.

The vaccine locks the "spike" protein into a shape which allows the immune system to be able to recognise and neutralise it.

UQ's Professor Trent Munro said beginning a large multi-arm study at Viroclinics Xplore was critical, before human testing, because it would establish a more comprehensive understanding of how the vaccine performs.

Originally published as UQ coronavirus vaccine set for overseas test


What Qld did in lockdown instead of drinking

Premium Content What Qld did in lockdown instead of drinking

Coronavirus Qld lockdown saw increase in illicit drug use

Fiery Premier sinks elbow into opponent

Premium Content Fiery Premier sinks elbow into opponent

Qld election debate: Premier pins hopes on coronavirus record

‘LAST RESORT’: APLNG confirms Western Downs job losses

Premium Content ‘LAST RESORT’: APLNG confirms Western Downs job losses

ORIGIN Energy has confirmed there will be job losses in the Western Downs.